Revelation Biosciences, Inc. (REVB): Total Assets
$11.58M
As of 2025-12-31
$12.50M
As of 2026-06-30
+28.2%
3-year compound annual growth
-31.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.58M | +74.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $6.62M | -45.8% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $12.21M | +121.9% | 2025-03-06, Balance as of period end |
| 2022-12-31 | $5.50M | +169.5% | 2024-09-23, Balance as of period end |
| 2021-12-31 | $2.04M | -97.2% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $74.16M | n/m | 2022-04-15, Balance as of period end |
| 2019-12-31 | $22.7K | n/a | 2021-06-16, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $11.58M | +74.9% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $11.58M | n/m |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $11.45M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $12.00M | +165.1% |
| MetaVia Inc. (MTVA) | 2025-12-31 | $11.12M | -31.6% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $11.09M | +279.5% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $11.06M | +265.8% |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | $12.15M | +198.2% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $11.04M | -56.8% |
Compare REVB, CURX, NCEL, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗